274.74

11.16% 27.21

Bio Rad Laboratories Inc (BIO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Bio Rad Laboratories Inc stock is traded at $274.74, with a volume of 447.76K. It is up +11.16% in the last 24 hours and down -7.98% over the past month. Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Previous Close:

$247.53

Open:

$274.72

24h Volume:

447.76K

Relative Volume:

1.32

Market Cap:

$7.38B

Revenue:

$2.59B

Net Income/Loss:

$168.80M

P/E Ratio:

45.23

EPS:

6.0748

Net Cash Flow:

$357.20M

1W Performance:

+12.86%

1M Performance:

-7.98%

6M Performance:

-10.60%

1Y Performance:

+10.65%

1-Day Range:

$267.83

$279.89

1-Week Range:

$236.73

$279.89

52-Week Range:

$211.43

$343.12

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Name

Bio Rad Laboratories Inc

Sector

Healthcare (1105)

Industry

Medical Devices (143)

Phone

(510) 724-7000

Address

1000 ALFRED NOBEL DRIVE, HERCULES

Employee

7,450

Twitter

@BioRadLifeSci

Next Earnings Date

2026-04-30

Latest SEC Filings

BIO's Discussions on Twitter

Compare BIO vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BIO Bio Rad Laboratories Inc	275.67	6.62B	2.59B	168.80M	357.20M	6.0748
ABT Abbott Laboratories	87.10	147.13B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	312.43	117.60B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	76.91	97.77B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	55.21	78.30B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	82.14	46.86B	6.30B	1.07B	1.09B	1.8406

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-07-26	Downgrade	Citigroup	Buy → Neutral
Oct-01-24	Upgrade	Citigroup	Neutral → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jun-03-24	Resumed	Jefferies	Hold
Apr-03-24	Downgrade	Citigroup	Buy → Neutral
Dec-07-23	Initiated	UBS	Buy
Jun-16-23	Initiated	Wells Fargo	Overweight
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Jan-28-22	Reiterated	Citigroup	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Oct-17-18	Initiated	Goldman	Buy
Sep-20-18	Initiated	Morgan Stanley	Equal-Weight
Feb-16-18	Downgrade	CL King	Buy → Neutral
Jul-13-17	Initiated	Wells Fargo	Outperform
Jun-28-17	Upgrade	Deutsche Bank	Hold → Buy
Jan-18-17	Initiated	Deutsche Bank	Hold
Oct-13-16	Initiated	CL King	Buy
May-06-15	Reiterated	Jefferies	Buy
Dec-18-09	Initiated	Maxim Group	Buy
Nov-06-09	Initiated	Jefferies & Co	Buy
Jul-17-09	Initiated	Soleil	Buy
Sep-26-07	Initiated	Banc of America Sec	Buy
Feb-23-07	Downgrade	Robert W. Baird	Outperform → Neutral

View All

Bio Rad Laboratories Inc Stock (BIO) Latest News

12:33 PM

Toyo Posts Upbeat Q1 Earnings, Joins Brady, Dominion Energy And Other Big Stocks Moving Higher On Monday - Benzinga

12:33 PM

10:55 AM

Bio-Rad (BIO) Sees 10.5% Surge in Stock Value - GuruFocus

10:55 AM

09:09 AM

Bio-Rad Laboratories (BIO) Stock Soars 13% on Elliott Management Investment News - GuruFocus

09:09 AM

08:54 AM

Why Is Bio-Rad Laboratories Stock Trending Now - Kalkine Media

08:54 AM

07:11 AM

Bio-Rad (BIO) Faces Pressure from Activist Investor Elliott - GuruFocus

07:11 AM

04:44 AM

Market Chatter: Bio-Rad Laboratories Draws Elliott Investment as Activist Investor Pushes for Turnaround - Moomoo

04:44 AM

01:19 AM

Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports - 102.7 WBOW

01:19 AM

01:03 AM

Dow Jones Top Company Headlines at 1 AM ET: Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - Moomoo

01:03 AM

12:46 PM

Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports - MSN

12:46 PM

12:32 PM

Elliott builds ‘sizeable’ stake in med tech firm Bio-Rad, WSJ reports - Investing.com Nigeria

12:32 PM

12:22 PM

Elliott Investment Management Takes Stake in Bio-Rad Laboratories (BIO) - GuruFocus

12:22 PM

May 17, 2026

Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports (BIO:NYSE) - Seeking Alpha

May 17, 2026

Bio-Rad (BIO) Faces Pressure from Activist Investor - GuruFocus

May 17, 2026

Exclusive | Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad - WSJ

May 17, 2026

Activist Elliott Builds Big Stake in Life-Science Tools Supplier Bio-Rad -- WSJ - Moomoo

May 17, 2026

Elliott builds ‘sizeable’ stake in med tech firm Bio-Rad, WSJ reports By Investing.com - Investing.com South Africa

May 17, 2026

Bio-Rad Is a Strategic Investor in Sartorius, With Around $5B Stake -- WSJ - Moomoo

May 17, 2026

Elliott Investment Management Has Sizable Stake in Bio-Rad Laboratories, Sources Say -- WSJ - Moomoo

May 17, 2026

Bio-Rad outlines 2026 currency-neutral revenue growth of -3% to +0.5% amid Middle East disruption - MSN

May 17, 2026

May 16, 2026

Bio-Rad Laboratories, Inc. Class B Trade Ideas — LS:862449 - TradingView

May 16, 2026

Number of shareholders of Bio-Rad Laboratories, Inc. – NYSE:BIO - TradingView

May 16, 2026

Number of shareholders of Bio-Rad Laboratories, Inc. Class B – LS:862449 - TradingView

May 16, 2026

May 15, 2026